A single arm phase II study to individualize dasatinib dosing based on trough levels and molecular response to maintain efficacy whilst minimising toxicity (CML12)
收藏Research Data Australia2024-08-03 收录
下载链接：
https://researchdata.edu.au/a-single-arm-toxicity-cml12/2538312
下载链接
链接失效反馈官方服务：
资源简介：
Dataset includes: Data for 80 patients over 60 with newly diagnosed CML, using desatinib and monitoring lung function Diagnostic data, treatment data, outcome data Cancer Australia demographic data -Year of birth -Aboriginal or Torres Strait Islander status (or Ethnicity)
提供机构：
Health Data Australia Contributor Records
